Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.
Richmond JM, Strassner JP, Zapata L Jr, Garg M, Riding RL, Refat MA, Fan X, Azzolino V, Tovar-Garza A, Tsurushita N, Pandya AG, Tso JY, Harris JE. Richmond JM, et al. Sci Transl Med. 2018 Jul 18;10(450):eaam7710. doi: 10.1126/scitranslmed.aam7710. Sci Transl Med. 2018. PMID: 30021889 Free PMC article.
Innate immune mechanisms in vitiligo: danger from within.
Richmond JM, Frisoli ML, Harris JE. Richmond JM, et al. Curr Opin Immunol. 2013 Dec;25(6):676-82. doi: 10.1016/j.coi.2013.10.010. Epub 2013 Nov 12. Curr Opin Immunol. 2013. PMID: 24238922 Free PMC article. Review.
Immunology and skin in health and disease.
Richmond JM, Harris JE. Richmond JM, et al. Cold Spring Harb Perspect Med. 2014 Dec 1;4(12):a015339. doi: 10.1101/cshperspect.a015339. Cold Spring Harb Perspect Med. 2014. PMID: 25452424 Free PMC article. Review.
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo.
Agarwal P, Rashighi M, Essien KI, Richmond JM, Randall L, Pazoki-Toroudi H, Hunter CA, Harris JE. Agarwal P, et al. Among authors: richmond jm. J Invest Dermatol. 2015 Apr;135(4):1080-1088. doi: 10.1038/jid.2014.529. Epub 2014 Dec 18. J Invest Dermatol. 2015. PMID: 25521459 Free PMC article.
A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.
Vanderweil SG, Amano S, Ko WC, Richmond JM, Kelley M, Senna MM, Pearson A, Chowdary S, Hartigan C, Barton B, Harris JE. Vanderweil SG, et al. Among authors: richmond jm. J Am Acad Dermatol. 2017 Jan;76(1):150-151.e3. doi: 10.1016/j.jaad.2016.06.015. J Am Acad Dermatol. 2017. PMID: 27986135 Free PMC article. Clinical Trial. No abstract available.
CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice.
Richmond JM, Masterjohn E, Chu R, Tedstone J, Youd ME, Harris JE. Richmond JM, et al. J Invest Dermatol. 2017 Apr;137(4):982-985. doi: 10.1016/j.jid.2016.10.048. Epub 2017 Jan 23. J Invest Dermatol. 2017. PMID: 28126463 Free article. No abstract available.
Mouse Model for Human Vitiligo.
Riding RL, Richmond JM, Harris JE. Riding RL, et al. Among authors: richmond jm. Curr Protoc Immunol. 2019 Feb;124(1):e63. doi: 10.1002/cpim.63. Epub 2018 Sep 25. Curr Protoc Immunol. 2019. PMID: 30253067 Free PMC article.
72 results